Ying Ye

Person

Martinsville, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperi...
- Patent number 11,660,302
- Issue date May 30, 2023
- Celgene Corporation
- Peter H. Schafer
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of immune-related and inflammatory diseases
- Patent number 11,524,950
- Issue date Dec 13, 2022
- Celgene Corporation
- Peter H. Schafer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperi...
- Patent number 10,980,812
- Issue date Apr 20, 2021
- Celgene Corporation
- Peter H. Schafer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidi...
- Patent number 10,596,179
- Issue date Mar 24, 2020
- Celgene Corporation
- Peter H. Schafer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidi...
- Patent number 10,245,266
- Issue date Apr 2, 2019
- Celgene Corporation
- Peter H. Schafer
- G01 - MEASURING TESTING
Information Patent Grant
Methods for measurement of inhibition of c-Jun N-terminal kinase in...
- Patent number 10,197,579
- Issue date Feb 5, 2019
- Signal Pharmaceuticals, LLC
- Gerald Scott Barden Horan
- G01 - MEASURING TESTING
Information Patent Grant
Methods for measurement of inhibition of c-Jun N-terminal kinase in...
- Patent number 9,513,297
- Issue date Dec 6, 2016
- Signal Pharmaceuticals, LLC
- Gerald Scott Barden Horan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...
- Publication number 20240041894
- Publication date Feb 8, 2024
- Celgene Corporation
- Peter H. Schafer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES
- Publication number 20230159490
- Publication date May 25, 2023
- Celgene Corporation
- PETER H. SCHAFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...
- Publication number 20220008427
- Publication date Jan 13, 2022
- Celgene Corporation
- Peter H. Schafer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES
- Publication number 20210122727
- Publication date Apr 29, 2021
- Celgene Corporation
- PETER H. SCHAFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...
- Publication number 20200360396
- Publication date Nov 19, 2020
- Celgene Corporation
- Peter H. Schafer
- G01 - MEASURING TESTING
Information Patent Application
3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...
- Publication number 20190262348
- Publication date Aug 29, 2019
- Celgene Corporation
- Peter H. Schafer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...
- Publication number 20170173029
- Publication date Jun 22, 2017
- Celgene Corporation
- Peter H. Schafer
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR MEASUREMENT OF INHIBITION OF C-JUN N-TERMINAL KINASE IN...
- Publication number 20170045531
- Publication date Feb 16, 2017
- Signal Pharmaceuticals, LLC.
- Gerald Scott Barden HORAN
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR MEASUREMENT OF INHIBITION OF C-JUN N-TERMINAL KINASE IN...
- Publication number 20160169908
- Publication date Jun 16, 2016
- Signal Pharmaceuticals, LLC.
- Gerald Scott Barden HORAN
- G01 - MEASURING TESTING
Information Patent Application
SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYL...
- Publication number 20150210650
- Publication date Jul 30, 2015
- Signal Pharmaceuticals, LLC.
- Antonio Christian Ferretti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES
- Publication number 20150038511
- Publication date Feb 5, 2015
- Celgene Corporation
- PETER H. SCHAFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
- Publication number 20140343058
- Publication date Nov 20, 2014
- Peter H. Schafer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Topical use of halosalicylic acid derivatives
- Publication number 20050136015
- Publication date Jun 23, 2005
- Derrick B. McKie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperi...

Treatment of immune-related and inflammatory diseases

3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperi...

3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidi...

3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidi...

Methods for measurement of inhibition of c-Jun N-terminal kinase in...

Methods for measurement of inhibition of c-Jun N-terminal kinase in...

Patents Applicationslast 30 patents

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...

TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...

TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...

METHODS FOR MEASUREMENT OF INHIBITION OF C-JUN N-TERMINAL KINASE IN...

METHODS FOR MEASUREMENT OF INHIBITION OF C-JUN N-TERMINAL KINASE IN...

SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYL...

TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES

TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

Topical use of halosalicylic acid derivatives